This article provides a comprehensive, evidence-based analysis for researchers and drug developers on the pivotal biological differences and clinical performance of 4-1BB and CD28 costimulatory domains in CAR constructs.
This article provides a detailed examination of 3D tumor organoids as advanced pre-clinical models for high-throughput drug screening (HTS).
This article provides a comprehensive guide for researchers and drug development professionals on 3D in vitro microfluidic models for immune-tumor cell interactions.
This article provides a comprehensive analysis of the pivotal role 3D bioprinting plays in standardizing organoid production, a critical bottleneck in biomedical research.
This article provides a comprehensive analysis of 3D bioprinting for tumor organoid generation, targeting researchers and drug development professionals.
This article provides a comprehensive overview for researchers, scientists, and drug development professionals on the critical role of Cancer Stem Cells (CSCs) in tumor persistence, relapse, and therapy resistance.
This article provides a systematic comparison of established and emerging molecular techniques for cancer diagnostics, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive guide to the analytical validation of cancer biomarker assays, a critical step for translating discoveries into reliable clinical and research tools.
This article provides a comprehensive overview of master protocol designs, a transformative approach for simultaneously evaluating multiple investigational drugs and/or cancer types within a single trial framework.
This article provides a comprehensive comparative analysis of Patient-Derived Xenograft (PDX) and Patient-Derived Organoid (PDO) models, two transformative technologies in preclinical oncology research.